Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Multispan
AddedFeb 15, 2024
UpdatedJun 18, 2026
Multispan

Multispan

Multispan Inc.: A biotech firm specializing in gene therapy research and custom drug discovery services.

HQ
Hayward, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Multispan Inc. is a biotech firm specializing in gene therapy research and custom drug discovery services. The company offers a range of services including custom compound profiling, cell line generation, antibody development, and frozen cell and membrane preparation. With a focus on cell engineering and high-throughput screening (HTS) assays, Multispan aims to lower costs and shorten the drug discovery timeline, ultimately helping to create better medicines.

Multispan has established itself as a leader in the biotech industry by consistently delivering high-quality assay services and innovative technologies. The company's commitment to empathy, integrity, and productivity has driven its success in developing effective medical solutions. Through its advanced cell engineering and HTS assay expertise, Multispan has made significant contributions to the field of drug discovery, impacting both the speed and efficiency of developing new therapies.

Multispan - Similar Companies

ExpressCells logo

ExpressCells

MultiCell Technologies logo

MultiCell Technologies

Spheringenics logo

Spheringenics

BridGene Biosciences logo

BridGene Biosciences

ElevateBio logo

ElevateBio

Spotlight Therapeutics logo

Spotlight Therapeutics

spotlighttx.com

Mosaic Biosciences logo

Mosaic Biosciences

mosaicbio.com

Cellworks logo

Cellworks

OmniAb logo

OmniAb

omniab.com

AnaBios logo

AnaBios

anabios.com

Discovery Innovations logo

Discovery Innovations

PhenoVista Biosciences logo

PhenoVista Biosciences

phenovista.com

BioAnalytics logo

BioAnalytics

Confluence Discovery Technologies logo

Confluence Discovery Technologies

Spinogenix logo

Spinogenix

spinogenix.com

Multispan - Quick Facts

Who are Multispan's competitors?

Companies similar to Multispan include ExpressCells, MultiCell Technologies, Spheringenics and BridGene Biosciences.

When was Multispan founded?

Multispan was founded in 2004.

Where is Multispan's headquarters located?

Multispan's headquarters is located in Hayward, CA, US.

When was Multispan's last funding round?

Multispan's most recent funding round was for $600k (USD) in October 2007.

How much has Multispan raised to-date?

As of Oct 1, 2007, Multispan has raised a total of $1.1M (USD).

How many employees does Multispan have?

Multispan has 11 employees as of Feb 5, 2024.

Multispan - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Drug Discovery
  • Gene Therapy
Tags
  • API
  • Consulting
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research